Elsevier, Journal of Ethnopharmacology, 1(146), p. 324-330, 2013
DOI: 10.1016/j.jep.2012.12.053
Full text: Download
ETHNOPHARMACOLOGICAL RELEVANCE: Couroupita guianensis Aublet, 'macacarecuia', 'abricó-de-macaco', 'castanha-de-macaco' and 'amêndoa-dos-andes', is found in tropical regions and widely used in the treatment of tumors, pain, and inflammatory processes. AIM OF THE STUDY: Ethanol extract and hexane and ethyl acetate fractions were evaluated in models of inflammatory pain (formalin-induced licking) and acute inflammation (carrageenan-induced peritonitis). MATERIALS AND METHODS: Ethanol extract, hexane and ethyl acetate fractions (10, 30 or 100mg/kg, p.o.) and the references drugs dexamethasone (5mg/kg), morphine (5mg/kg, s.c.), and acetylsalicylic acid (100mg/kg, p.o.) were tested in formalin-induced licking response and carrageenan-induced peritonitis. RESULTS: All three doses from C. guianensis fractions significantly reduced the time that the animal spent licking the formalin-injected paw in first and second phases. However, only higher doses (30 and 100mg/kg) were able to inhibit the leukocyte migration into the peritoneal cavity after carrageenan injection. In this model, the 100mg/kg dose almost abolished the cell migration. In was also observed that protein concentration resulted from extravasation to the peritoneum and nitric oxide (NO) productions were significantly reduced. Cytokines productions were differently affected by the treatment. TNF-α production was reduced after ethanol extract and ethyl acetate fraction pre-treatment whereas hexane fraction had effect only with 100mg/kg dose. IL-1β production was inhibited only after hexane fraction pre-treatment. The inhibitory effect observed was not due to a direct cytotoxic effect on cells nor to a NO-scavenger activity. The effect was due to a direct inhibition on NO production by the cells. CONCLUSIONS: the results show that C. guianensis fractions have anti-inflammatory effect, partly due to a reduction on cell migration and a inhibition on cytokines and inflammatory mediators production.